Suppr超能文献

休闲大麻合法化:从非法来源转向合法来源的促进因素和障碍。

Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source.

作者信息

Robertson Kirsten, Thyne Maree

机构信息

Department of Marketing, University of Otago, Dunedin, New Zealand.

出版信息

Prev Med Rep. 2021 Nov 16;24:101639. doi: 10.1016/j.pmedr.2021.101639. eCollection 2021 Dec.

Abstract

Illicit markets persist in places where recreational cannabis has been legalized. This study aimed to identify perceived facilitators/barriers of switching from an illicit to a licit cannabis source. Using a cross-sectional qualitative approach, 529 students, from one New Zealand university, completed a survey investigating the facilitators/barriers to switching through two open-ended questions. Perceived facilitators for switching included: safety (63.1%); price (42.7%); legal, no risk of convictions (35.3%); increased accessibility (32.3%); product diversity (14.2%). Perceived barriers included: price (66.4%); judgement (36%); regulation (28.9%); loyalty to current supplier (27.2%); reduced accessibility (13.2%). The findings provide recommendations for policies aimed at tipping people in favor of a licit over an illicit source. Avoiding arrest/convictions, and easier access, were not primary facilitators for switching. Thus, providing a licit market might be insufficient in the absence of other competitive factors, such as communicating improved product safety. Competitive pricing and regulation (tetrahydrocannabinol strength/quantity limits) were also barriers. Given legal markets aimed at minimizing harm are constrained with competing in these areas, it is significant that our findings identified other barriers which could be overcome, including limiting surveillance and quantity limits and positioning stores to preserve anonymity. The findings also highlight that loyalty to current illicit suppliers will be a significant barrier.

摘要

在娱乐用大麻已合法化的地方,非法市场依然存在。本研究旨在确定从非法大麻来源转向合法大麻来源的可感知促进因素/障碍。采用横断面定性研究方法,来自新西兰一所大学的529名学生完成了一项调查,通过两个开放式问题来探究转向的促进因素/障碍。可感知的转向促进因素包括:安全性(63.1%);价格(42.7%);合法,无定罪风险(35.3%);可及性提高(32.3%);产品多样性(14.2%)。可感知的障碍包括:价格(66.4%);评判(36%);监管(28.9%);对当前供应商的忠诚度(27.2%);可及性降低(13.2%)。研究结果为旨在促使人们选择合法而非非法来源的政策提供了建议。避免被捕/定罪以及更便捷的获取并非转向的主要促进因素。因此,在缺乏其他竞争因素(如宣传提高产品安全性)的情况下,提供合法市场可能并不够。竞争性定价和监管(四氢大麻酚强度/数量限制)也是障碍。鉴于旨在将危害降至最低的合法市场在这些领域面临竞争限制,我们的研究结果确定了其他可以克服的障碍,包括限制监管和数量限制以及合理布局商店以保护匿名性,这一点具有重要意义。研究结果还凸显出,对当前非法供应商的忠诚度将是一个重大障碍。

相似文献

1
Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source.
Prev Med Rep. 2021 Nov 16;24:101639. doi: 10.1016/j.pmedr.2021.101639. eCollection 2021 Dec.
2
Cannabis consumers' preferences for legal and illegal cannabis: evidence from a discrete choice experiment.
BMC Public Health. 2024 Sep 4;24(1):2397. doi: 10.1186/s12889-024-19640-1.
3
Implications of marijuana purchase task based demand functions for optimal legal pricing of cannabis.
Int J Drug Policy. 2021 Sep;95:103271. doi: 10.1016/j.drugpo.2021.103271. Epub 2021 May 25.
4
The supply-side effects of cannabis legalization.
J Cannabis Res. 2022 Jul 22;4(1):40. doi: 10.1186/s42238-022-00148-7.
6
Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis.
Addiction. 2019 Jan;114(1):112-118. doi: 10.1111/add.14437. Epub 2018 Oct 10.
7
The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
BMC Health Serv Res. 2020 Oct 27;20(1):977. doi: 10.1186/s12913-020-05756-8.
8
Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
Drug Alcohol Rev. 2020 May;39(4):337-346. doi: 10.1111/dar.13069. Epub 2020 Apr 14.
10
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9.

引用本文的文献

本文引用的文献

1
Control of Recreational Cannabis in a New Zealand University Sample: Perceptions of Informal and Formal Controls.
Subst Abuse. 2020 Aug 28;14:1178221820953397. doi: 10.1177/1178221820953397. eCollection 2020.
2
Legal cannabis-what's in it?
Addiction. 2021 Feb;116(2):231-232. doi: 10.1111/add.15203. Epub 2020 Aug 11.
3
Consumer perceptions of 'legal' and 'illegal' cannabis in US states with legal cannabis sales.
Addict Behav. 2021 Jan;112:106563. doi: 10.1016/j.addbeh.2020.106563. Epub 2020 Jul 17.
6
Initial indicators of the public health impacts of non-medical cannabis legalization in Canada.
EClinicalMedicine. 2020 Mar 20;20:100294. doi: 10.1016/j.eclinm.2020.100294. eCollection 2020 Mar.
7
Prevalence of Tobacco Use Among Rural-Dwelling Individuals Who Inject Drugs.
JAMA Netw Open. 2020 Mar 2;3(3):e200493. doi: 10.1001/jamanetworkopen.2020.0493.
8
Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization.
Int J Drug Policy. 2020 Feb;76:102632. doi: 10.1016/j.drugpo.2019.102632. Epub 2019 Dec 24.
9
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
Lancet. 2019 Oct 26;394(10208):1580-1590. doi: 10.1016/S0140-6736(19)31789-1. Epub 2019 Oct 23.
10
Should the supply of cannabis be legalised now?
BMJ. 2019 Jul 3;366:l4473. doi: 10.1136/bmj.l4468.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验